AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03795571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine 1000mg/m2，d1，d5
Study NCT03795571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin 75mg/m2，d1
Study NCT03795571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone 40mg/d，d1\~d4
Study NCT03795571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide Oral Capsule
Description: Lenalidomide 10mg/d、15mg/d、20mg/d、25mg/d d1\~d10； 21days a cycle
Study NCT02627170 — intervention group
Intervention type: DEVICE
Intervention: dynamic Scheimpflug analyzer (corneal visualization Scheimpflug technology [Corvis ST], OCULUS, Wetzlar, Germany)
Study NCT02877329 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-delivered ACT
Description: Therapist-guided Internet-delivered ACT (acceptance and commitment therapy) for 8 weeks
Study NCT04642300 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Holmich Protocol
Description: Module 1 (1st two weeks):~i)Isometric adduction ii)Abdominal sit-ups iii)Isometric adduction iv)Compound abdominal sit-ups and hip flexion v)Balance exercise on wobble board vi)One-foot exercise on sliding board~Module 2 (from 3rd week):~i)Leg abduction and adduction exercise carried out in side lying ii)Low back extension exercise prone on the end of bench iii)One leg weight pulling abduction/adduction standing iv)Abdominal sit ups v)One leg coordination exercise vi)Training in sideways motion vii)Balance exercise on wobble board
Study NCT04642300 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Myofascial Release Technique
Description: 1. Transverse friction massage: 10 mins on painful area of adductor-tendon insertion into pubic bone~2. Stretching of adductor muscles, hamstrings muscles and hip flexors:3 times and each stretch is 30s with Contract relax technique
Study NCT01578200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lanthanum Carbonate
Study NCT01578200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium Carbonate
Study NCT04054700 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: distal upper rehabilitation robot
Description: Intervention with distal upper rehabilitation robot
Study NCT04054700 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: proximal upper rehabilitation robot
Description: Intervention with proximal upper rehabilitation robot
Study NCT00762359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lansoprazole
Description: Lansoprazole 15 mg, capsules, orally, once daily and gefarnate placebo-matching capsules, orally, twice daily for up to 12 to 30 months.
Study NCT00762359 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gefarnate
Description: Gefarnate 50 mg, capsules, orally, twice daily and lansoprazole placebo-matching capsules, orally, once daily for up to 12 to 30 months.
Study NCT02490436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Randomized cross-over between cetuximab and placebo
Study NCT02490436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Randomized cross-over between cetuximab and placebo
Study NCT02198014 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual Therapy
Description: 5 minutes. Thermotherapy shallow to 50 cm away from the knee. 15 minutes. Joint traction, grade I-II. Fixation of distal femur with cinch and manual fixation of proximal tibia. Patient in prone position and the traction is carried out in the submaximal ranges of flexion and extension.~10 minutes. Passive muscle stretching of quadriceps (within the limits of mobility), through compression muscle, passive muscle stretching and relaxation of muscle.~10 minutes. Isometric and resisted exercises of quadriceps, in submaximal ranges, of flexion and extension.~10 minutes. Proprioception exercises with unipodal support, with and without visual support, and posterior destabilization.~10 minutes. Local cryotherapy with ice pack.
Study NCT02198014 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Physiotherapy
Description: * Theory. Introduction to hemophilia: clinic and treatment; Anatomy and biomechanics of knee; Anatomy of ankle musculature; Function of muscles and haematomas treatment; Haemarthrosis, synovitis and arthropathy: clinical manifestations; Proprioception: definition and importance in hemophilia; and Physical activity and sport: risks and benefits.~* Practice: exercises in favor of gravity; active exercises for mobility and pain management; knee proprioception exercises; isometric and isotonic exercises of quadriceps; swimming and cycling technique.
Study NCT00928486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide 25mg PO for (days 1 - 21) of a 28-day cycle
Study NCT00928486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone 40 mg by mouth (PO) daily (QD) on days 1-4, 9-12 and 17-20 of each 28 day cycle
Study NCT01048879 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: pharmacokinetic blood sampling
Description: blood samples collected to assess oseltamivir concentrations
Study NCT01048879 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: pharmacokinetic blood and dialysate sampling
Description: blood and dialysate samples collected and assayed for oseltamivir concentrations
Study NCT04558177 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Direct current stimulator
Description: HDCprog connected to a direct current stimulator, controls the number of stimulations (maximum 99), the intensity (up to 1.5mA per channel), the duration (maximum 20min), and the minimum interval between two consecutive simulations (max 1168 hours). A sham condition is also available which will ramp the stimulation to a preset maximum level and then immediately reduces the stimulation to 0.
Study NCT04558177 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Direct current stimulator
Description: HDCprog connected to a direct current stimulator, controls the number of stimulations (maximum 99), the intensity (up to 1.5mA per channel), the duration (maximum 20min), and the minimum interval between two consecutive simulations (max 1168 hours). A sham condition is also available which will ramp the stimulation to a preset maximum level and then immediately reduces the stimulation to 0.
Study NCT02197312 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: NobelProcera Bridge Shaded Zirconia
Study NCT03770260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixazomib Citrate
Description: Given PO
Study NCT03770260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pevonedistat
Description: Given IV
Study NCT03386981 — intervention group
Intervention type: OTHER
Intervention: blood and saliva tests
Description: Blood and saliva will be tested for: bone turnover markers, cytokines, chemokines, adipokines, myokines and hormones regulating bone and energy metabolism
Study NCT03282656 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: single infusion of autologous bone marrow derived CD34+ HSC cells transduced with the lentiviral vector containing a short-hairpin RNA targeting BCL11a
Description: single infusion of autologous bone marrow derived CD34+ HSC cells transduced with the lentiviral vector containing a short-hairpin RNA targeting BCL11a
Study NCT03732339 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GILUPI CellCollector®
Description: Use of GILUPI CellCollector® to detect CTC
Study NCT01760057 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online HIV testing motivational videos and messages sent via mobile-phone text messaging, e-mail or instant messaging
Study NCT01760057 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Standard online message with an invitation for free HIV testing similar in content to other Peruvian websites
Study NCT01109264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine hydrochloride injection
Description: d1-2, i.v.gtt, 100mg/m2, 28 days per cycle, at most 6 cycles
Study NCT01109264 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chlorambucil
Description: d1-d2, d15-d16, p.o., 0.4mg/kg/day, 28 days per cycle, at most 6 cycles
Study NCT04388592 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse Practitioner (NP) Led Care Arm
Description: The NP will conduct baseline consultation visits with the participants and their caregivers (if applicable). They will then initiate treatment for the participant's symptoms as appropriate (ie: depression treatment for depressive symptoms, fatigue management strategies), connect to resources in the community as needed (ie: rehabilitation programs, home care support, psychologist support) to optimize functioning. There will be scheduled follow visits and/or phone calls with the NP at 3 and 6 months.
Study NCT03021057 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pembrolizumab
Description: 200mg i.v. once every 3 weeks Number of Cycles: until progression or unacceptable toxicity develops
Study NCT04516746 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AZD1222
Description: AZD1222 is a recombinant replication-defective chimpanzee adenovirus expressing the SARS-CoV-2-5 surface glycoprotein.
Study NCT04516746 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Commercially available 0.9% (n/V) saline for injection.
Study NCT00095420 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social skills training targeting children with autism
Description: Sessions will focus on improving the social skills of autistic children. Thirty-minute sessions will be held twice a week for 6 weeks.
Study NCT00095420 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social skills training of peers without autism
Description: Sessions will involve educating the peers of autistic children to increase their acceptance of their autistic peers. Thirty-minute sessions will be held twice a week for 6 weeks.
Study NCT01393834 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping
Description: Delay cord clamping for 30 seconds after birth
Study NCT01393834 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Milking of the cord
Description: Milking of the cord 4 times in 10 seconds
Study NCT02908061 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery Radical Cystectomy
Description: All surgeries will be performed in an open or laparoscopic fashion.
Study NCT02908061 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery Radical Cystectomy
Description: All surgeries will be performed in an open or laparoscopic fashion.
Study NCT02908061 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrapro mesh
Description: Surgery Mesh Placement. All surgeries will be performed in an open or laparoscopic fashion.
Study NCT02498925 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Activation
Description: Behavioral Activation is a psychosocial treatment for depression focused on gradually re-engaging patients with sources of reinforcement and reward in their environment (e.g., increasing activites and interpersonal interactions). In contrast to Cognitive Behavioral Therapy, and as the name implies, Behavioral Activation focuses on behavioral change strategies to improve mood and places little emphasis on cognitive restructuring techniques.
Study NCT05953181 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Active surveillance
Description: Patients enrolled in the active surveillance arm will undergo diagnostic evaluations every 3 months in the first year after completion of neoadjuvant treatment, every 4 months in the second year, every 6 months in the third year and yearly in the 4th and 5th year of follow up, or when symptoms or results of any diagnostic test require shorter assessment intervals. In the active surveillance arm, surgical resection will be offered only to those patients, in whom a locoregional regrowth is highly suspected or proven, without any signs of distant dissemination.
Study NCT05953181 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Active surveillance
Description: Patients enrolled in the active surveillance arm will undergo diagnostic evaluations every 3 months in the first year after completion of neoadjuvant treatment, every 4 months in the second year, every 6 months in the third year and yearly in the 4th and 5th year of follow up, or when symptoms or results of any diagnostic test require shorter assessment intervals. In the active surveillance arm, surgical resection will be offered only to those patients, in whom a locoregional regrowth is highly suspected or proven, without any signs of distant dissemination.
Study NCT02081924 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kisspeptin 0.1
Description: Participants will receive kisspeptin hormone at a dose rate of 0.1nmol/kg/hour via a subcutaneous pump device for 8 days during the early follicular phase of their menstrual cycle.~LH, FSH and oestradiol will be measured on day 1 and 8, at 10minute intervals for 8 hours and on Days 3 and 5 they will have a single blood measurement of the same hormones.
Study NCT02081924 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Participants will receive placebo (saline) via a subcutaneous pump device for 8 days during the early follicular phase of their menstrual cycle.~LH, FSH and oestradiol will be measured on day 1 and 8, at 10minute intervals for 8 hours and on Days 3 and 5 they will have a single blood measurement of the same hormones.
Study NCT02081924 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kisspeptin 0.3
Description: Participants will receive kisspeptin hormone at a dose rate of 0.3 nmol/kg/hour via a subcutaneous pump device for 8 days during the early follicular phase of their menstrual cycle.~LH, FSH and oestradiol will be measured on day 1 and 8, at 10minute intervals for 8 hours and on Days 3 and 5 they will have a single blood measurement of the same hormones.
Study NCT02081924 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kisspeptin 1.0
Description: Participants will receive kisspeptin hormone at a dose rate of 1.0 nmol/kg/hour via a subcutaneous pump device for 8 days during the early follicular phase of their menstrual cycle.~LH, FSH and oestradiol will be measured on day 1 and 8, at 10minute intervals for 8 hours and on Days 3 and 5 they will have a single blood measurement of the same hormones.
Study NCT04543396 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Description: A training program designed to enhance core strength, stability, and function will be performed on the Tonal device. Training sessions will occur twice weekly for eight weeks. Performance of this program will be supervised by a designated and clinically trained research team member who will not conduct the statistical analysis and subsequently not be blinded to Group assignment. The program will last approximately 20 minutes in length and incorporate the a series of progressive exercises.
Study NCT03767933 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: 10mg/kg, maximum 600mg; Oral liquid
Study NCT03767933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: 10mg/kg, maximum 600mg; Oral liquid
Study NCT03767933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: 15mg/kg, maximum 1000mg; Oral liquid
Study NCT03767933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydromorphone
Description: 0.05mg/kg, maximum 5 mg; Oral liquid
Study NCT03767933 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen placebo
Description: Oral liquid
Study NCT03767933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen placebo
Description: Oral liquid
Study NCT03767933 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydromorphone placebo
Description: Oral liquid
Study NCT03767933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydromorphone placebo
Description: Oral liquid
Study NCT03859024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone
Description: oxycodone tablet
Study NCT03859024 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone
Description: oxycodone tablet
Study NCT03859024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: acetaminophen tablet
Study NCT03859024 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: acetaminophen tablet
Study NCT03859024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: gabapentin tablet
Study NCT03859024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: celebrex
Description: Celebrex tablet
Study NCT03859024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: bupivacaine injection
Study NCT03859024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg
Description: ibuprofen tablet
Study NCT03859024 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen 800 mg
Description: ibuprofen tablet
Study NCT03859024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone injection
Study NCT03354949 — intervention group
Intervention type: OTHER
Intervention: Measurement of sitting postural control of the adult (MCPAA)
Description: The Adult Seated Postural Control Measure 2.0 (MCPAA 2.0) is a clinical evaluation tool for sitting postural control of adult clients using a locomotion aid. It thus allows the evaluation of the two variables inherent to the postural control sit, the alignment of body segments and the influence between movement and posture.~It can also be used to evaluate the changes in seated postural control due to changes over time or to an adaptation of the sitting posture.~Assessment of wheelchair pain in the spine and ischia by a self-evaluation scale (EVA).~the speed of propulsion by a wheelchair.
Study NCT04721860 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Backward Locomotion Treadmill Training (BLTT)
Description: 12-training sessions of reverse treadmill training (no bodyweight support) over four weeks.
Study NCT04721860 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Forward Locomotion Treadmill Training (FLTT)
Description: 12-training sessions of forward treadmill training (no bodyweight support) over tfour weeks.
Study NCT03095495 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Heated Humidified High Flow Nasal Cannula
Description: HHHFNC therapy is a simple to use system that delivers warm and moist air/oxygen mixture at high flow rates that generate positive airway pressure
Study NCT03095495 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Heated Humidified High Flow Nasal Cannula
Description: HHHFNC therapy is a simple to use system that delivers warm and moist air/oxygen mixture at high flow rates that generate positive airway pressure
Study NCT03095495 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Therapy (Low Flow Nasal Cannula)
Description: will be used only if the patient needs oxygenation and Rescue HHHFNC will be used if the patient needs PICU
Study NCT03205800 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mini-screw
Description: Placement of a mini-screw
Study NCT04088877 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The participants will attend the exercise facility at Wellspring two times a week. Sessions are completed under the supervision of an exercise physiologist and the duration of each session ranges from 1.0 - 1.5 hours. Each session includes a warm up on an aerobic exercise machine, a full body progressive RET program followed by balance and stretching exercises.
Study NCT04088877 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Art Sculpting Class
Description: The sculpting program will take place once a week for 2 hours over an 8-week period. Sessions will be themed around body image and facilitated by an artist and registered psychologist who will lead the group in art techniques and self-reflection, respectively. Each group session will focus on a theme related to body image, and the participants will have the opportunity to reflect through their art and social interactions with one another.
Study NCT03679923 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: NEM® brand eggshell membrane
Description: Dietary supplement for the support of joint health.
Study NCT03679923 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT02363335 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: mixed meal
Study NCT02363335 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: mixed meal
Study NCT02363335 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Roflumilast/Sitagliptin
Description: Both Roflumilast and Sitagliptin together
Study NCT02363335 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Description: This is already known to increase GLP-1 \&amp; GIP secretion.
Study NCT02363335 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Roflumilast
Description: This is already known to increase GLP-1 \&amp; GIP secretion
Study NCT03678064 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lokomat
Description: 16 sessions total. Provided by study PT twice weekly for a period of 8 weeks